Meta-IQ is an innovative Danish Biotech  company developing innovative treatments for Secondary progressive multiple sclerosis ( SP-MS).

Meta-IQ is preparing to raise the necessary funding to take the compound MIQ-001 through phase 2.

If you are interested in hearing more about the company or projects or are interested in joining the investment round then please contact us.

Contact

Søren Nielsen, CEO

E: sn@meta-iq.com

P: + 45 25 39 41 37


Martin G. Kloth, CFO

E: martin.kloth@meta-iq.com

P: +45 21 35 56 80